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Abstract  
Men and women world-wide suffer from alcohol use disorder (AUD), defined as a chronic brain disease 
characterized by the loss of an individual’s control over their alcohol intake. Emerging evidence has 
found that AUD is likely linked to specific neuroimmune responses in the brain. Neuroimmune responses 
can be triggered by numerous events such as infection, trauma, and stress, and they result in the increased 
expression of various proinflammatory molecules and receptor proteins. The purpose of this research was 
to further understand the relationship between the neuroimmune cascade triggered by activation of the 
toll-like receptor-7 protein (TLR7) that canonically detects viral single-stranded RNA, focusing on its 
effect on ethanol drinking behavior. Male and female Long Evans rats were trained to self-administer 
15% ethanol solution in operant chambers and their drinking patterns were tracked during daily 30-minute 
sessions. Every 15 days, 10 mg/kg of imiquimod, a specific TLR7 agonist, was injected intraperitoneally 
in the male and female rats in order to induce a neuroimmune cascade. Increased alcohol self-
administration was observed the day following imiquimod injections for both the male and female 
groups; however, there were some differences in the expression of the behavior. In females, this effect 
was seen after the first injection while the male group did not show this increase until the third injection 
suggesting a difference in TLR7 sensitization between sexes. Gene expression data was analyzed via real-
time RTPCR from the nucleus accumbens core, a region in the brain implicated in drug addiction and 
reward in order to test for expression of TLR7 as well as TLR3, a receptor that detects double-stranded 
RNA. Ultimately, further testing may provide insight necessary in order to understand which specific 
factors of this neuroimmune cascade are responsible for the phenomena observed. Conclusively, 
understanding which specific neurobiological factors of neuroimmune activation contribute to the 
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INTRODUCTION: 
 Alcohol use disorder (AUD) is characterized as a brain disease associated with a loss of 
control over alcohol intake. Our research focuses on understanding the link between AUD and 
the body’s innate immune system due to emerging evidence that AUD is likely linked to specific 
neuroimmune responses activated by the body’s innate immune system (Crews et. al. 2011). 
Neuroimmune responses can be triggered by numerous events such as infection, trauma, or stress 
and they result in an increase in the expression of various proinflammatory molecules and 
receptor proteins that can have lasting effects on the neurons associated with the brain’s reward 
system (Crews et. al., 2017a; Crews and Vetreno, 2016). Toll-like receptor proteins (TLRs) are a 
class of pattern-recognition receptors (PRRs) utilized by the innate immune system that detect 
molecular signatures known as pathogen-associated molecular patterns (PAMPS) or damage-
associated molecular patterns (DAMPS). Situated on microglia in the brain, TLR activation 
induces a neuroimmune cascade that can result in changes in the neurocircuitry and gene 
expression in the brain (Okun et al. 2011). Recent studies have shown an essential relationship 
between their activation and addiction-like behavior (Crews et al. 2017a). In human studies, the 
post-mortem brains of individuals with a history of AUD showed increased expression levels of 
TLRs (Crews et al. 2017b). Previously our lab has found that activating TLR3, which normally 
detects double-stranded RNA, in Long Evans rats via the agonist polyinosinic: polycytidylic 
(poly (I:C)) resulted in significantly increased alcohol self-administration (Randall et. al., 2019). 
Interestingly, the activation of TLR3 resulted in increased expression of TLR7, a related receptor 
that typically detects single-stranded RNA. The increased expression of TLR7 in response to 
TLR3 activation catalyzed our interest in targeting TLR7 in order to observe its effects on 
operant alcohol self-administration in rats.   
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 TLR7 is encoded on the X chromosome and also escapes X chromosome inactivation, 
presumably making it more highly expressed in female immune cells than in males (Souyris et. 
al., 2018). Evidence suggests that there are sex-specific differences in TLR immune activation; 
specifically, females tend to show increased activation of proinflammatory responses compared 
to their male counterparts (Klein and Flanagan 2016). We were interested in understanding how 
activating TLR7 via agonist imiquimod would affect alcohol self-administration, and how the 
neuroimmune cascade induced by the same dose of imiquimod would differ between sex and if 
this would have any implications on alcohol self-administration.  
 Here, we administered four 10 mg/kg doses of imiquimod once every 15 days to male 
and female adult Long Evans rats and then monitored alcohol self-administration through daily 
operant chamber sessions. After the fourth imiquimod injection, gene expression data was 
analyzed using real-time RTPCR on the nucleus accumbens core (AcbC), a brain region 
implicated in modulating reward and drug addiction in order to analyze expression of the TLRs. 
We found that activation of TLR7 via agonist imiquimod increased alcohol self-administration in 
both males and females. In females we observed increased alcohol self-administration after the 
initial imiquimod injection while in males we observed increased alcohol self-administration 
after repeated imiquimod injections. These experiments seek to further the understanding of how 
neuroimmune activation, specifically via TLR7, impacts alcohol self-administration. Ultimately, 
understanding the neurobiological factors that contribute to AUD is important for the 
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METHODS: 
Animals 
 Adult male (n=24) and female (n=24) Long Evans rats (Envigo-Harlan, Indianapolis, IN) 
arrived at 7 weeks old and were handled daily for 1 week prior to the start of the experiment. All 
rats were doubled housed in ventilated cages in same-sex pairs. Rats had ad-libitum access to 
food and water in the home cage. The rats were kept in a temperature and humidity-controlled 
colony room that ran on a 12-hour light/dark cycle (lights on at 07:00). All experiments were 
conducted during the light cycle. Animals were under the care of the veterinary staff from the 
Division of Comparative Medicine at UNC-Chapel Hill. All of the procedures followed the 
guidelines established by the NIH Guide to Care and Use of Laboratory Animals and 
institutional guidelines.  
 
Chambers/Apparatus 
 Self- administration chambers (Med Associates, Fairfax, VT) were used in order to test 
for changes in drinking patterns and to track alcohol consumption and locomotor rate. Self-
administration sessions that lasted 30 minutes were held each day Monday through Friday for 
each individual rat. The chambers had two levers on opposing sides of the chambers, with a 
corresponding cue light above each lever. The levers were on a fixed-ratio 2 reinforcement 
schedule (FR-2), meaning two lever presses resulted in one reinforcement. Upon pressing the left 
lever twice, the corresponding cue light was illuminated and a tone was turned on as 0.1 mL of 
ethanol (EtOH) solution was delivered into the receptacle on the left side. Upon pressing the 
right lever, which is an inactive lever, there was no programmed consequence. The chambers 
were individually located within a larger sound-attenuating cubicle containing a fan that was 
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meant to circulate air and mask outside noise. The chambers were also equipped with infrared 
photo-beams in order to track locomotor activity during a given session. During a self-
administration session, the amount of ethanol administered, the number of times each lever was 
pressed, locomotor rate, and number of head-pokes into the left and right receptacle were 
recorded.  
 
Ethanol Self-Administration Training  
Rats first underwent a 16-hour overnight session with 10% sucrose 2% alcohol (w/v; 
10S/2A) in order to learn the association between pressing the alcohol active lever and receiving 
alcohol in the left receptacle. Following this session, rats underwent a sucrose fading procedure 
as previously described (Besheer et al., 2010).  Briefly, rats trained on daily 30-minute sessions 
in which the sucrose concentration slowly decreased and the alcohol concentration increased in 
the following order: 10S/2A, 10S/5A, 10S/10A, 5S/10A, 5S/15A, 15A, 20A, 15A. Following the 
sucrose fading, 15% ethanol (v/v) served as the final and maintenance condition for daily self-
administration sessions over the next 24 days. 
 
Imiquimod Injections 
 Imiquimod (batch 0000025236, Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 
45% hydroxypropyl-beta-cyclodextrin (Acros Organics, Geel, Belgium). Every 15 days, a 10 
mg/kg dose of imiquimod was administered intraperitoneally (IP) while control rats received 
equivalent injections of hydroxypropyl-beta-cyclodextrin.  
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Tissue Collection and Real Time RTPCR 
 Rats were anesthetized with carbon dioxide (CO2) (Airgas, Radnor, PA) and then brains 
and spleens were collected 24 hours after the 4th injection. Spleens were weighed and adjusted 
according to body weight. RT-PCR (reverse transcription [RT] followed by real-time polymerase 
chain reaction [PCR]) was conducted to quantify levels of mRNA of target neuroimmune genes 
in the nucleus accumbens core (AcbC). Total mRNA was extracted and reverse transcribed as 
previously described (Vetreno and Crews, 2012; Vetreno et al., 2013). Real-time PCR using 
SYBR green PCR Master Mix (Life Technologies, Carlsbad, CA) was run with an initial 
activation for 10 min at 95 C, followed by 40 cycles of denaturation (95 C, 15s), 
annealing/extension (57-58 C, 1 min), and finally a melt curve. The primer sequences are 
presented in Table 1. The threshold cycle (CT) of each target product was determined and the 





 Data are expressed as mean ± SEM. To analyze behavioral data, unpaired t-tests were 
used to compare the ethanol lever responses, ethanol intake (g/kg; calculated from the number of 
reinforcers received) and locomotor activity on the day of imiquimod injection and the day after 
versus control rats. Real-time PCR results were assessed using unpaired t-tests to compare gene 
expression of target mRNA in imiquimod rats versus control rats within sex. Unpaired t-tests 
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were used to compare spleen weight adjusted to body weight of imiquimod rats versus control 
rats. Statistical significance was declared at p<0.05. 
 
Experiments: 
Experiment 1 - Effects of imiquimod on ethanol self-administration in male rats   
Every 15 days, self-administration trained male Long Evans rats were injected with imiquimod 
(0 or 10 mg/kg, IP) 2 hours prior to a standard 30-minute self-administration session (n=12 
control, n=12 imiquimod). Daily self-administration was resumed the following day for 15 days. 
Four rounds of imiquimod and control injections were given in total over a 46-day span. To 
examine the effects of imiquimod on expression of TLR7 and TLR3 in the AcbC, animals were 
sacrificed 24 hours after the 4th round of imiquimod injections for tissue and organ collection.  
 
Experiment 2 - Effects of imiquimod on ethanol self-administration in female rats   
The exact experimental design of Experiment 1 was replicated with 24 female rats (n=12 control, 
n=12 imiquimod) in order to observe any sex-specific differences.  
 
RESULTS:  
Repeated TLR7 activation via imiquimod increased alcohol self-administration in males  
An increasing trend in alcohol self-administration was observed the day after each subsequent 
imiquimod injection in the male rats, with the greatest increase in alcohol self-administration 24 
hours after the third injection (Fig.1A/Fig.2A). After the second injection there is a strong 
increasing trend (p= 0.058) in ethanol intake (grams of ethanol consumed/kg of body weight) 
observed in the imiquimod group. Intake was significantly (t(22)=2.44, p< 0.05) higher in the 
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imiquimod group 24 hours after the third injection (Fig.1A). Alcohol lever presses appear to 
increase in the imiquimod group the day after the second injection and are significantly (t(22)= 
2.22, p< 0.05) higher the day after the third injection (Fig.2A). Two hours after injections two 
through four, rats in the male imiquimod group had significantly reduced ethanol intake (2nd 
injection: t(22)= 3.85, p<0.05; 3rd injection: t(22)= 6.59, p<0.05; 4th injection: t(22)= 5.02, 
p<0.05) as well as alcohol lever presses (2nd injection: t(22)= 3.96, p<0.05; 3rd injection: t(22)= 
7.3, p<0.05; 4th injection: t(22)= 5.31, p<0.05). (Fig. 1A/Fig.2A).  
 
Initial TLR7 activation via imiquimod increased alcohol self-administration in females 
A significant increase in alcohol self-administration was observed in the female imiquimod 
group the day following the first injection (Fig.1/Fig.2). Ethanol intake (g/kg) was significantly; 
higher in the female imiquimod group 24 hours after the first injection (t(22)=2.56, p< 0.05 and 
third injection (t(22)=2.088, p<0.05; Fig.1B). Alcohol lever presses were significantly higher in 
the female imiquimod group 24 hours after the first injection (t(22)= 2.17, p< 0.05) and there is a 
trend for an increase in alcohol lever presses 24 hours after the third injection (p=0.087; Fig.2B). 
Female imiquimod rats had reduced ethanol intake as well as alcohol lever presses on the days of 
imiquimod injections one through three (Fig.1B/Fig.2B); however, ethanol intake (t(22)=3.71, 
p<0.05) and alcohol lever presses (t(22)=3.90, p<0.05) were only significantly reduced on the 
day of the third injection. 
 
Reduced locomotion and weight loss suggest imiquimod induced an immune response in 
both sexes 
 
Imiquimod is a known agonist of the toll-like receptor 7 protein; however, in order to determine 
whether a 10 mg/kg dose of imiquimod was sufficient to activate a significant immune response 
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several variables were tested. Some of the main symptoms of a stereotyped sickness response are 
reduced activity and weight loss, two variables we tracked for daily changes. As a general trend, 
indications of a sickness response were observed as soon as two hours after imiquimod injections 
that affected the imiquimod groups behaviorally during the self-administration sessions on the 
day of injections. The locomotor rates of the male and female imiquimod groups were generally 
significantly lower on days of injections (Fig.3); however, there were some differences in the 
patterns observed. The locomotor rate of the male imiquimod group was not affected by the first 
injection. It wasn't until the second imiquimod injection that the locomotor rates of the male 
imiquimod group were significantly lower than the control group (t(22)=3.30, p<0.05), and this 
trend was consistent with each subsequent imiquimod injection (third injection: t(22)=2.43, 
p<0.05; fourth injection: t(22)=4.54, p<0.05) (Fig.3A). Comparatively, the locomotor rate of the 
female imiquimod group was significantly lower than the control group after the initial 
imiquimod injection (t(22)=2.84, p<0.05) and with each subsequent injection a similar trend was 
observed (2nd injection: p=0.056; 3rd injection: t(22)=3.83, p<0.05; 4th injection: p=0.061) 
(Fig.3B).  
 The weights of both male and female rats in the imiquimod groups showed a decreasing 
trend the day following injections (Fig.4) and then resumed normal weight gain until the 
subsequent injection.  
Since spleens are a storage site for immune cells and enlarged spleens, termed 
splenomegaly, are indicative of a hyperactive immune system, they were collected and weighed 
24 hours after the fourth imiquimod injection in order to assess whether an immune response had 
been activated in the imiquimod groups. Spleen weights were adjusted to account for differences 
in body weight. Both male and female rats in the imiquimod group had significantly heavier 
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Repeated activation of TLR7 increases gene expression of TLRs in males and females  
 
In order to determine how the TLR7 agonist imiquimod alters toll-like receptor gene expression 
in rat AcbC, real-time RTPCR was utilized in order to determine expression of TLR7 and TLR3 
in the imiquimod group compared to the control group. Male imiquimod rats had significantly 
increased expression of TLR3 in the AcbC 24 hours after the fourth injection compared to the 
control group (t(20)=3.22, p<0.05) (Fig.6A). Similarly, female imiquimod rats also had 
significantly increased expression of TLR-3 in the AcbC 24 hours after the fourth injection 
compared to the control group (t(22)=2.20, p<0.05) (Fig.6B). While there was increased 
expression of TLR3 in both males and females, only imiquimod females had increased 
expression of TLR7 in the AcbC 24 hours after the fourth injection compared to the control 
group (t(22)=4.73, p<0.05) (Fig.7B). There was not increased expression of TLR7 in the AcbC 




In this study, we evaluated the effects of the neuroimmune cascade triggered by TLR7 
activation via agonist imiquimod on operant ethanol self-administration including mRNA levels 
of the neuroimmune genes TLR3 and TLR7 in the AcbC. Our results indicate that activation of 
TLR7 via imiquimod increased operant ethanol self-administration, induced an immune 
response, and increased gene expression of the neuroimmune genes TLR3 and TLR7.  
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 Both male and female rats in the imiquimod group showed increases in ethanol intake 
and alcohol lever presses 24 hours after imiquimod injections; however, this increase was 
observed in the female imiquimod group after the first injection while imiquimod males showed 
this increase after repeated injections. Imiquimod females had significantly increased alcohol 
self-administration 24 hours after the first and third injections, which remained elevated for 
another day before dropping back to baseline drinking levels (Fig.1B/Fig.2B). An important 
consideration for the ethanol self-administration data is that rats experienced weight loss after 
injection days, affecting the ethanol intake (g/kg) calculated for that day. This may explain why 
ethanol intake (g/kg) after the third injection is significantly higher for imiquimod females while 
alcohol lever presses after the third injection are not considered significant despite showing a 
trend for an increase in alcohol lever presses. Alcohol self-administration did not increase after 
the second imiquimod injection, which could potentially be attributed to a short-term change in 
sensitization of the TLR7 receptor after the initial injection. Following a similar trend, overall 
changes in drinking behavior were observed after the initial imiquimod injection. Imiquimod 
females drank less on injection days starting after the first injection and continuing after the 
second and third injections (Fig.1B/Fig.2B). There was no decrease in alcohol self-
administration on the day of the fourth injection, again potentially indicating a short-term change 
in sensitization of the TLR7 receptor.  
 Comparatively, imiquimod males did not show changes in drinking behavior after the 
initial imiquimod injection. Starting with the second injection, alcohol lever presses as well as 
ethanol intake (g/kg) increased sequentially with each injection with the greatest increase in 
alcohol self-administration occurring 24 hours after the third injection. Likewise, male 
imiquimod rats drank less on the days of injections two through four. This increase in alcohol 
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self-administration along with each injection indicates that repeated TLR7 activation in males is 
necessary to change drinking behavior and increase alcohol self-administration.   
 As a general trend, increases in alcohol self-administration were only observed on days 
where male or female imiquimod rats had decreased alcohol self-administration the day before. 
The decrease in alcohol self-administration on the day of injections coincides with days where 
rats had reduced locomotor activity and is likely an indication of a sickness response which is 
lowering the rats’ motivation to work for alcohol. On days where no sickness response seems to 
have been induced (first injection in males), alcohol self-administration was not increased the 
following day. This suggests that the activation of an immune response is likely related to 
drinking behavior.  
 A 10 mg/kg dose of imiquimod was sufficient in activating an immune response in both 
males and females; however, there were differences between the patterns of immune response 
activation in either group. Decreased locomotor rate during an alcohol self-administration 
session is suggestive of an activated sickness response by the body’s immune system. Following 
the same trend observed with alcohol self-administration, imiquimod females had reduced 
locomotor rates on the days of each injection starting on the initial injection, while imiquimod 
males had reduced locomotor rates on the days of injections two through four (Fig.3). Weight 
loss is another indication of an activated sickness response by the body’s immune system (Kelley 
et al. 2003). Both imiquimod males and females experienced weight loss after injection days; 
however, normal weight gain resumed almost immediately the next day (Fig.4). The current 
experiments show that TLR7 activation induces a rapid (2 hour) immune response with acute 
sickness behavioral effects. Over time with repeated imiquimod injections, the spleens of both 
male and female imiquimod rats were significantly heavier compared to control rats (Fig.5). The 
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enlarged spleens of the imiquimod rats suggests that their immune system was hyperactive and 
that there was increased supply of immune cells being stored for defense.  
 Since we observed increased ethanol self-administration 24 hours after imiquimod 
injections, we wanted to understand what was happening genetically in the nucleus accumbens 
core at this 24 hour post-injection time point. Specifically, we were interested in assessing 
differences in expression of TLRs in rat AcbC due to evidence that there is a relationship 
between TLR activation and alcohol intake (Blednov et al. 2011). Our lab has previously found 
that activation of TLR3 resulted in increased expression of TLR7 in male rat Acb (Randall et al. 
2019), which catalyzed our interest in targeting TLR7 activation. Our results indicate that 
repeated activation of TLR7 via imiquimod induces increased gene expression of TLR7 as well 
as TLR3. Both imiquimod males and females had significantly higher expression of TLR3 
compared to control groups in the AcbC. Interestingly, only the imiquimod females had 
increased expression of TLR7 compared to the control group at this time point. The mechanism 
of TLR7 induced increases in ethanol self-administration and gene expression are complex. 
There seems to be a signaling relationship between TLR3 and TLR7 where activation of one 
results in the increased expression of the other. This is not unlikely due to the fact that TLR3 and 
TLR7 are both endosomal receptors that upon activation, trigger similar neuroimmune cascades 
(Nishiya et al. 2005).  
 An important consideration for the current experiments is that TLR7 escapes X 
chromosome inactivation, presumably making it more highly expressed in females than in males 
(Souyris et al. 2018). Differences in TLR7 expression could potentially be a variable affecting 
TLR7 sensitization in the males and females. Sex differences in immune activation has been well 
documented, with females generally mounting a stronger immune response than males (Marriot 
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and Huet-Hudson 2006; Schwartz and Bilbo 2012). There is evidence that females generally 
produce higher levels of proinflammatory cytokines than males (Aulock et al. 2006; Drew and 
Chavis 2000; Loram et al. 2012); and that following TLR activation specifically, females tend to 
show increased activation of proinflammatory responses (Klein and Flanagan 2016). The 
findings from the current experiments suggest that differences in immune function and activation 
likely contribute to the different patterns of drinking behavior observed in the male and female 
groups; however, future studies with larger sample sizes will allow us to have a more 
comprehensive understanding on whether these different patterns are sex-specific.  
 Taken together, the findings presented support a connection between TLR7 neuroimmune 
activation and ethanol self-administration as well as TLR gene expression. Numerous studies 
emphasize the important role that neuroimmune activation plays in the development of addiction 
(Coleman and Crews 2018) as well as the regulatory effects of the innate immune system on 
alcohol consumption (Crews et al. 2017a). Future experiments should assess how prolonged 
activation of TLR7, potentially by administering imiquimod injections multiple days in a row, 
would effect ethanol self-administration and gene expression of TLRs. Also, utilizing 
microinjections to administer imiquimod locally in the brain could provide a better 
understanding on how drinking behavior would be affected if the peripheral sickness response is 
eliminated. The findings presented support emerging evidence that neuroimmune activation can 
affect alcohol drinking behavior and likely contributes to the development of AUD. Future work 
to improve the understanding of which specific neurobiological factors of neuroimmune 
activation contribute to the pathology of AUD is critical for the development of enhanced 
treatment options.  
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Imiquimod increases alcohol intake (g/kg) in males and females. Male and female Long Evans rats 
received four imiquimod injections (10 mg/kg) over a 46-day span. Daily operant ethanol self-
administration sessions were held to track changes in drinking behavior. Ethanol intake (g/kg) was 
calculated by dividing estimated grams of alcohol consumed by body weight. (A) Repeated imiquimod 
injections increased ethanol intake in the male imiquimod group. (B) The initial imiquimod injection 
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Figure 2.  
Imiquimod increases alcohol lever presses in males and females. Male and female Long Evans rats 
received four imiquimod injections (10 mg/kg) over a 46-day span. Daily operant ethanol self-
administration sessions were held to track changes in drinking behavior. Active lever presses count the 
number of times rats are pressing the alcohol lever which indicates their motivation for alcohol. (A) 
Repeated imiquimod injections increased alcohol lever presses in the male imiquimod group the day after 
the third injection. (B) In females, the initial imiquimod injection increased alcohol lever presses 24 hours 
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Figure 3.  
Reduced activity on days of imiquimod injections. Locomotor rate, calculated by number of beam 
breaks during operant chamber sessions, assesses total activity on a given day. (A) Male imiquimod rats 
had reduced activity two hours after each injection other than the first injection. (B) Female imiquimod 
rats had reduced activity two hours after the first injection and similar results were observed with each 
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Figure 4.  
Weight loss in imiquimod groups the day after injections. Body weights were measured daily 
immediately before self-administration sessions. Weight loss was observed the day following injections in 
both imiquimod males (A) and females (B). Normal weight gain resumed the following day. The results 
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Figure 5.  
Effect of imiquimod injections on spleen weight. Spleens were collected and weighed 24 hours after the 
fourth imiquimod injection. Spleen weights were adjusted to account for differences in body weight. Both 
imiquimod males (A) and females (B) had significantly heavier spleens compared to control groups. The 
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Figure 6.  
Increased TLR3 expression in male and female 
rat AcbC. Repeated imiquimod injections 
increased mRNA expression of TLR3 in 
imiquimod male (A) and female (B) AcbC 24-
hours after the fourth injection. The results are 
the means ± SEM. *=p<0.05 
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Male TLR7 expression in AcbC 24 hours post inj#4 
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Figure 7.  
Increased TLR7 expression in female rat AcbC. 
(A) Repeated imiquimod injections had no effect on 
mRNA expression of TLR7 in males. (B) 
Imiquimod females had increased TLR7 mRNA 
expression in the AcbC 24 hours after the fourth 
injection. The results are the means ± SEM. 
*=p<0.05 
